Sangam India Ltd. Grants Employee Stock Options totaling 5,08,500 under ESOP Scheme, 2022
Sangam India Ltd. has approved the grant of employee stock options to eligible employees through its Employee Stock Option Scheme, 2022. The options were granted by the company's Nomination and Remuneration Committee and are designed to motivate employees within the organization.The grant comprises a total of 5,08,500 stock options. Under the terms of the scheme, each option grants the holder the right to receive one equity share of Sangam India Ltd., which is valued at Rs 10/- each upon exercise. The entire allocation covers 5,08,500 Equity Shares of the Company, priced at Rs 10/- per share.
The options were granted under the provisions of the SEBI (Share Based Employees Benefits and Sweat Equity) Regulations, 2021.
Key terms related to the options grant include vesting periods and exercise timelines:
| Feature | Details |
|---|---|
| Total Options Granted | 5,08,500 |
| Exercise Value per Option | One equity share of Rs 10/- each |
| Vesting Period | A minimum of one year and a maximum of seven years from the grant date |
| Option Exercise Period | Two years from the date of vesting |
As noted in the scheme details, while the options have been granted to eligible employees, no options have been exercised, and no money has been realized from the exercise thus far.
SANGAMIND Stock Price Movement
On Friday, shares of Sangam (India) Limited slipped by 0.11% to settle at ₹552.5. The equity traded for a volume of 17,615 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.